| Synonyms: | |
| Status: | Phase 1 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 5V1Y8T4RB6 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Epidermal growth factor receptor erbB1 inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Carcinoma, Hepatocellular | 2 | D006528 | ClinicalTrials |
| Carcinoma, Squamous Cell | 2 | D002294 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Nasopharyngeal Neoplasms | 2 | D009303 | ClinicalTrials |
| Small Cell Lung Carcinoma | 2 | D055752 | ClinicalTrials |
| Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4594549 |
| FDA SRS | 5V1Y8T4RB6 |
CONTENTS